Suspected VITT blood clotting case after Johnson & Johnson COVID-19 vaccination
European regulators urged to crack down on missing clinical trial results
6 May 2021How soon will the COVID-19 pandemic end? It depends.
6 May 2021Suspected VITT blood clotting case after Johnson & Johnson COVID-19 vaccination
University of Utah Health announces a suspected case of vaccine-induced thrombotic thrombocytopenia (VITT), also called thrombosis and thrombocytopenia syndrome (TTS), after receiving the Johnson & Johnson COVID-19 vaccine. Confirmation of the diagnosis by the U.S. Centers for Disease Control and Prevention (CDC) is pending.
